2026 NPPES data Child & Adolescent Psychiatry Physician NPI 1467456707 MD
Verify on CMS →

VEERAIAH KARUMANCHI, MD

Child & Adolescent Psychiatry Physician in TUCSON, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
660
Medicare Part D claims · 134 beneficiaries · Child & Adolescent Psychiatry Physician avg: 600
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
61.8147/100
▼ 21 pts below national avg 83.1 · [object Object]

What the federal data shows

VEERAIAH KARUMANCHI, MD reported a CMS MIPS final score of 61.8147/100 — below the 83.1 national average — and filed 660 Medicare Part D claims in 2023.

61.8147/100
MIPS score · -21 vs avg
660
Part D claims, 2023
98%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

VEERAIAH KARUMANCHI, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

62 6th percentile higher than 6% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

VEERAIAH KARUMANCHI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about VEERAIAH KARUMANCHI, MD?

Below national average

NPI registry status

Active

Issued 06/01/2005

NPI 1467456707

Primary specialty

Child & Adolescent Psychiatry Physician

Mid-sized

6,160 US NPIs in this specialty

Medicare Part D claims

660 10% vs specialty avg

2023 prescription claims

Specialty avg: 600

MIPS final score

61.8147/100 21.285299999999992% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Arizona

How Child & Adolescent Psychiatry Physician compares to other specialties among Arizona providers

Arizona providers

Child & Adolescent Psychiatry Physician share within Arizona

1. Child & Adolescent Psychiatry Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Child & Adolescent Psychiatry Physician share within Arizona

Medicare quality performance — MIPS

VEERAIAH KARUMANCHI, MD's 2023 MIPS final score plotted against the Child & Adolescent Psychiatry Physician national average

Below national average
MIPS Final Score
61.8147/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Child & Adolescent Psychiatry Physician) — 61.8147/100 vs national avg 83.1

0%100%National avg83%61.8%
MIPS final score (Child & Adolescent Psychiatry Physician) — 61.8147/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

VEERAIAH KARUMANCHI, MD appears in the CMS NPPES registry as a Child & Adolescent Psychiatry Physician provider holding MD credentials at 502 W. 29TH STREET, TUCSON, AZ, 85713, with a listed phone of (520) 884-9920. NPI 1467456707 was issued on 06/01/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KARUMANCHI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 660 prescription claims written by this provider, covering 134 Medicare beneficiaries and totaling roughly $44K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 61.8147/100 for the 2023 performance year (Quality 39.3823, Cost 100), compared with the national average of 83.1.

Child & Adolescent Psychiatry Physician is a mid-sized specialty nationwide, with 6,160 enrolled providers across 54 states and an average of 600 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

502 W. 29TH STREET
TUCSON, AZ 85713

Provider Details

NPI 1467456707
Specialty Child & Adolescent Psychiatry Physician
Credentials MD
Gender Male
NPI Issued 06/01/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

61.8147
Final Score
Avg: 83.1
39.3823
Quality
100
Cost
0
Promoting Interoperability

Reporting: Group practice

Brand vs generic prescribing mix · Generic-heavy

VEERAIAH KARUMANCHI, MD — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 660 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

660
Total Claims
$44K
Total Drug Cost
134
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
666
Total Day Supply
18,470
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$19K
Generic Drug Cost
$25K

Patient Demographics

Average Patient Age
60.0 years
Avg HCC Risk Score
1.67
Gender Split
49% female / 51% male
Age Distribution
<65: 85, 65-74: 39, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What VEERAIAH KARUMANCHI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trazodone Hcl
75
Sertraline Hcl
65
Buspirone Hcl
60
Benztropine Mesylate
38
Haloperidol
27
Quetiapine Fumarate
26
Aripiprazole
24
Risperidone
24
Lamotrigine
20
Gabapentin
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Child & Adolescent Psychiatry Physician Overview

How VEERAIAH KARUMANCHI, MD fits within the Child & Adolescent Psychiatry Physician landscape nationally.

6,160
Child & Adolescent Psychiatry Physician Providers in US
54
States with Child & Adolescent Psychiatry Physician
600
Avg Claims per Provider

VEERAIAH KARUMANCHI, MD's 660 claims are above the specialty average of 600.

Nearby Child & Adolescent Psychiatry Physician Providers in Arizona

Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as KARUMANCHI.

Compare Child & Adolescent Psychiatry Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is VEERAIAH KARUMANCHI, MD's specialty?
VEERAIAH KARUMANCHI, MD specializes in Child & Adolescent Psychiatry Physician and practices in TUCSON, Arizona. Credentials: MD.
How much does VEERAIAH KARUMANCHI, MD prescribe under Medicare Part D?
In 2023, VEERAIAH KARUMANCHI, MD wrote 660 Medicare Part D claims totaling $44K in drug costs for 134 beneficiaries.
What is VEERAIAH KARUMANCHI, MD's Medicare quality score?
VEERAIAH KARUMANCHI, MD has a CMS MIPS Final Score of 61.8147/100 (Quality: 39.3823, Cost: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is VEERAIAH KARUMANCHI, MD located?
VEERAIAH KARUMANCHI, MD is located at 502 W. 29TH STREET, TUCSON, AZ, 85713. Phone: (520) 884-9920.
What is VEERAIAH KARUMANCHI, MD's NPI number?
VEERAIAH KARUMANCHI, MD's National Provider Identifier (NPI) is 1467456707, issued on 06/01/2005.
Does VEERAIAH KARUMANCHI, MD prescribe more brand-name or generic drugs?
VEERAIAH KARUMANCHI, MD's prescribing is 2% brand-name and 98% generic drugs by claim count, with $19K in brand drug costs.
How many Child & Adolescent Psychiatry Physician providers are there in the US?
There are 6,160 Child & Adolescent Psychiatry Physician providers across 54 states in the US. The average Child & Adolescent Psychiatry Physician provider writes 600 Medicare Part D claims per year.
What drugs does VEERAIAH KARUMANCHI, MD prescribe most often?
Based on 2023 Medicare Part D data, VEERAIAH KARUMANCHI, MD's most frequently prescribed drugs include Trazodone Hcl, Sertraline Hcl, Buspirone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does VEERAIAH KARUMANCHI, MD accept Medicare?
VEERAIAH KARUMANCHI, MD appears in CMS Medicare data with 660 Part D claims and 134 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify VEERAIAH KARUMANCHI, MD's credentials?
VEERAIAH KARUMANCHI, MD's NPI is 1467456707 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology